BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30728472)

  • 1. Antibodies and venom peptides: new modalities for ion channels.
    Wulff H; Christophersen P; Colussi P; Chandy KG; Yarov-Yarovoy V
    Nat Rev Drug Discov; 2019 May; 18(5):339-357. PubMed ID: 30728472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venom-derived modulators of epilepsy-related ion channels.
    Chow CY; Absalom N; Biggs K; King GF; Ma L
    Biochem Pharmacol; 2020 Nov; 181():114043. PubMed ID: 32445870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Voltage-Gated Sodium Channel Peptide Toxins from Animal Venom: Pharmacological Probes and Analgesic Drug Development.
    Wu Y; Ma H; Zhang F; Zhang C; Zou X; Cao Z
    ACS Chem Neurosci; 2018 Feb; 9(2):187-197. PubMed ID: 29161016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating autoimmune disorders with venom-derived peptides.
    Shen B; Cao Z; Li W; Sabatier JM; Wu Y
    Expert Opin Biol Ther; 2017 Sep; 17(9):1065-1075. PubMed ID: 28695745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.
    Zhang AH; Sharma G; Undheim EAB; Jia X; Mobli M
    Neurosci Lett; 2018 Jul; 679():35-47. PubMed ID: 29684532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches to pain relief using venom-derived peptides.
    Hogg RC
    Curr Med Chem; 2006; 13(26):3191-201. PubMed ID: 17168706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
    Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
    J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venom-Derived Peptides Inhibiting Voltage-Gated Sodium and Calcium Channels in Mammalian Sensory Neurons.
    Yousuf A; Sadeghi M; Adams DJ
    Adv Exp Med Biol; 2021; 1349():3-19. PubMed ID: 35138607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium Channels and Venom Peptide Pharmacology.
    Israel MR; Tay B; Deuis JR; Vetter I
    Adv Pharmacol; 2017; 79():67-116. PubMed ID: 28528674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
    Klint JK; Senff S; Rupasinghe DB; Er SY; Herzig V; Nicholson GM; King GF
    Toxicon; 2012 Sep; 60(4):478-91. PubMed ID: 22543187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine-Based Selection of Drugs That Target Ion Channels from Combinatorial Venom Peptide Libraries.
    Zhang H; Du M; Xie J; Liu X; Sun J; Wang W; Xin X; Possani LD; Yea K; Lerner RA
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9306-10. PubMed ID: 27197631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain.
    Gui J; Liu B; Cao G; Lipchik AM; Perez M; Dekan Z; Mobli M; Daly NL; Alewood PF; Parker LL; King GF; Zhou Y; Jordt SE; Nitabach MN
    Curr Biol; 2014 Mar; 24(5):473-83. PubMed ID: 24530065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of functional antibodies targeting ion channels.
    Wilkinson TC; Gardener MJ; Williams WA
    J Biomol Screen; 2015 Apr; 20(4):454-67. PubMed ID: 25473082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel perspectives in cancer therapy: Targeting ion channels.
    Arcangeli A; Becchetti A
    Drug Resist Updat; 2015; 21-22():11-9. PubMed ID: 26183291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
    Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
    PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Ion Channels by Cysteine-Rich Peptides: From Sequence to Structure.
    Mobli M; Undheim EAB; Rash LD
    Adv Pharmacol; 2017; 79():199-223. PubMed ID: 28528669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venom-derived peptides inhibiting Kir channels: Past, present, and future.
    Doupnik CA
    Neuropharmacology; 2017 Dec; 127():161-172. PubMed ID: 28716449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-gated potassium channels as therapeutic targets.
    Wulff H; Castle NA; Pardo LA
    Nat Rev Drug Discov; 2009 Dec; 8(12):982-1001. PubMed ID: 19949402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-targeting sodium and calcium channels using venom peptides for the treatment of complex ion channels-related diseases.
    Cardoso FC
    Biochem Pharmacol; 2020 Nov; 181():114107. PubMed ID: 32579958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The voltage-gated potassium channel K
    Tajti G; Wai DCC; Panyi G; Norton RS
    Biochem Pharmacol; 2020 Nov; 181():114146. PubMed ID: 32653588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.